Stockreport

H.C. Wainwright Affirms Biogen Inc. (BIIB) Buy Rating on Lupus Franchise Prospects [Yahoo! Finance]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF Wainwright reiterated a ‘Buy' rating on the stock and a $194 price target. The positive stance echoes the research firm's confidence about the company's promising lupus [Read more]